Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Arkray to Distribute Iris Urine Analyzer in Japan

By HospiMedica staff writers
Posted on 21 May 2004
Under a four-year agreement, Iris International, Inc. More...
(Chatsworth, CA, USA), has agreed for Arkray, Inc. (Kyoto, Japan), to distribute its new iQ200 automated urine microscopy analyzer in Japan. Arkray is a Japanese manufacturer and supplier of medical devices.

Under the terms of the agreement, Arkray will be the exclusive distributor in Japan for the importation, marketing, sales, servicing, and support of the iQ200 instrument and consumables product line. The iQ will be marketed under Arkray's Aution family of products. When the iQ200 analyzer is working in tandem with the Arkray Aution Max AX-4280 automated urine chemistry analyzer through software developed by Iris, the result is the iQ200 System, the only fully integrated platform in the world performing complete urinalysis, both chemistry and microscopy, notes Iris.

In a similar arrangement, Iris announced in March 2004 that the company had renewed an exclusive four-year agreement with Arkray Global Business, Inc., a subsidiary company, to market its AX-4280 automated urine chemistry analyzer in the United States. Iris is also the nonexclusive distributor of the Arkray Aution JET AJ-4270, a semi-automated urine chemistry analyzer and related products targeting hospital emergency rooms and satellite laboratories.

"With the introduction of our new iQ200 product platform in both the United States and Japanese markets, the relationship between Iris and Arkray truly has come full circle,” said Cesar Garcia, president and CEO of Iris.




Related Links:
Iris
Arkray

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.